Commissariat à l'Énergie Atomique et aux Énergies Alternatives
发明人:
申请号：
EP10190258.3
公开号：
EP2305242A3
申请日:
2006.11.03
申请国别(地区):
EP
年份:
2012
代理人:
摘要：
The present application relates to compositions and methods for treating neurologic disorders. The present application more particularly discloses the identification of new genes and metabolic pathways involved in neurologic disorders, which provide novel targets and approaches for treating said disorders and for screening biologically active compounds. The present invention also provides various products and constructs, such as probes, primers, vectors, recombinant cells, which can be used to implement the above methods. The invention may be used to detect or treat various neurologic disorders, in various subjects, including mammalian subjects, particularly human beings.
